Effects of the new psychoactive substances diclofensine, diphenidine, and methoxphenidine on monoaminergic systems.

Luethi, Dino; Hoener, Marius C; Liechti, Matthias E

Luethi, Dino; Hoener, Marius C; Liechti, Matthias E.

Afiliação

Luethi D; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Schanzenstrasse 55, CH-4031 Basel, Switzerland.
Hoener MC; Neuroscience Research, pRED, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Liechti ME; Division of Clinical Pharmacology and Toxicology, Department of Biomedicine, University Hospital Basel and University of Basel, Schanzenstrasse 55, CH-4031 Basel, Switzerland. Electronic address: matthias.liechti@usb.ch.

Eur J Pharmacol ; 819: 242-247, 2018 Jan 15.

Article em En | MEDLINE | ID: mdl-29225192

Assuntos

Monoaminas Biogênicas/metabolismo; Psicotrópicos/farmacologia; Animais; Isoquinolinas/farmacologia; Proteínas de Membrana Transportadoras/metabolismo; Camundongos; Células NIH 3T3; Piperidinas/farmacologia

Palavras-chave

Diclofensine; Diphenidine; Methoxphenidine; Monoamine; New psychoactive substance

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psicotrópicos / Monoaminas Biogênicas Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google